Lyell Stock

lyellbiotech.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $1.04B

Lyell Immunopharma is a developer of curative cell-based immunotherapies for any cancer, with a focus on CAR-Ts and solid tumors.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Lyell before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Lyell before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Lyell’s Stock

Can you buy Lyell’s stock?
You can no longer buy Lyell’s stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
Can you sell Lyell’s stock?
You can no longer sell stock of Lyell on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
What is Lyell’s stock price?
The stock price of Lyell is $1.97 as of 1/18/24.
What is Lyell’s stock ticker symbol?
The ticker symbol of Lyell is LYEL.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.


Management Team

Premal Patel MD
Chief Medical Officer
Akira Matsuno
Chief Financial Officer & Head of Corporate Development
Richard Klausner MD
Founder, President, Board Member & Chief Executive Officer

Board Members

Richard Klausner MD
Robert Nelsen
ARCH Venture Partners
Cathy Friedman
Hans Bishop
Updated on: Jun 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.